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The aims of this study were to describe asthma management and morbidity in patients attending general 
practitioners in Australia, and to assess the relationship between patient reports and those of their general 
practitioner (GP). The sample comprised consecutive patients attending 46 general practitioners chosen at 
random in five regions of New South Wales, Australia. A total of 4538 patients were screened, 607 (13.4%) 
reported ever having diagnosed asthma, and the 501 who reported asthma in the previous 12 months 
completed a detailed questionnaire. Three hundred and thirty-four patients also had information about their 
asthma management recorded by their GP. The patient questionnaire asked about asthma symptoms, therapy, 
lung function measurement, and asthma-related morbidity. The GP questionnaire asked the doctor to record 
similar information about the patients. 
Two-thirds of the patients used regular inhaled &agonist medication, and one-half reported using 
preventive therapy. Only 24% owned a peak flow meter and 9% had a written plan of action for asthma 
attacks. Although preventive therapy and airway function assessment were more common in those with 
frequent symptoms (>2-3 times per week), this group were still sub-optimally managed. In the matched 
sample (n = 334), doctors reported prescribing bronchodilator and preventive medication, measuring airway 
function and recommending peak flow meter use more often than suggested lay patient-reported data. The 
study concludes that many patients do not attend for regular review, and that management remains 
sub-optimal, particularly in young adults. Data from patient surveys may underestimate clinical practice, as 
assessed from doctors’ records. This should lead to patient-derived estimates of management being interpreted 
with caution in epidemiological studies. Further attention to patient understanding and compliance with 
prescribed asthma management advice is needed in order to better manage asthma in the community. 
Introduction the 1990 National Health Survey (5), and was treated 
Asthma is an important public health concern in 
Australia, affecting 20% of children and 8% of adults 
at any given time (1). The prevalence, mortality and 
morbidity from asthma are higher in Australia and 
New Zealand than in the U.K. or other European 
countries, in spite of similar consensus approaches to 
therapy (2,3), comparable smoking prevalence rates 
and similar health care systems. On account of its 
prevalence, asthma presents first in general practice, 
and is typically managed in that setting (4). Asthma 
was amongst the leading causes of chronic illness in 
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at 3.7% of patient encounters in the recent Australian 
general practice morbidity survey (6). 
Many epidemiological studies, using patient- 
reported data, have demonstrated that asthma 
remains sub-optimally treated in population and 
general practice settings (7-9). Major problems with 
management appear to include an over-reliance on 
&agonist bronchodilators, and under-utilization of 
inhaled steroids and other preventive medication. In 
addition, few patients measure and monitor their 
asthma with a peak flow meter, or use written action 
plans to guide their actions when asthma symptoms 
or PEF rates worsen. 
Some U.K. studies have suggested that there has 
been a recent improvement in asthma management in 
general practice (lo), with an increase in the use of 
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preventive therapy (inhaled corticosteroids or cromo- 
glycate) and in the frequency of airway function 
measurement by both doctors and patients. Other 
studies have shown such improvements following 
specific interventions in the setting of general practice 
(11,12), although this is not a consistent finding 
(13,14). 
The first objective of this study was to assess 
asthma management received by a random sample of 
patients attending general practitioners in New South 
Wales, Australia. Comparisons with published guide- 
lines for optimal management were sought, specifi- 
cally the need for preventive therapy, regular doctor 
and patient monitoring of severity, and regular medi- 
cal review (2). The second objective was to determine 
the extent to which asthma management reported by 
patients was the same as that recorded by their 
general practitioner. 
The GPs questionnaire was completed at or after 
the consultation, using the patient’s medical record. 
General practitioners were asked about the patient’s 
current prescribed therapy and management, and 
recent utilization of the practice and other health 
services. Doctors were only asked to complete sur- 
veys for the subset of patients who had been treated 
for asthma at the practice surveys for the subset of 
patients who had been treated for asthma at the 
practice during the preceding 12 months. 
Methods 
The study was undertaken between August and 
December 1991. General practitioners (GPs) were 
selected at random from the Medicare list in three 
urban Sydney regions of different socio-economic 
status and an inland and coastal rural town in New 
South Wales. General practitioners were defined as 
practitioners providing at least 1500 GP services 
under Medicare in the previous year. A sample of 140 
eligible practitioners were approached, and 52 agreed 
to participate. Of these, 46 finally contributed data to 
the study. The practitioners who participated were 
slightly younger than those who did not, but did not 
differ by gender or type of practice. At least nine 
practices were recruited from each area. 
Epidemiological surveys often describe the preva- 
lence of asthma management practices using patient 
self-report. In this study, GP perceptions were chosen 
as the ‘gold standard’ as they had access to medical 
records of patient management, and the patients’ 
perceptions compared to them. Overall agreement 
was assessed using the kappa statistic, which adjusts 
crude percent agreement for chance (16). In addition, 
the sensitivity (Se) and specificity (Sp) of patient 
responses compared to their doctors’ were calculated. 
These demonstrated where misclassification in the 
estimates of asthma management occurred. Sensitiv- 
ity was the proportion of doctor-defined positive 
statements [such as prescribed inhaled corticosteroid 
(ICS) medication] which were reported by the 
patient. Specificity was the proportion of all negative 
doctor responses for each characteristic that were 
also patient negative. The positive predictive value 
(+PV) here was the proportion of patients with 
positive report of therapy or management who have a 
positive finding reported by their doctor. It is more 
clinically useful than the test characteristic measures 
(Se and Sp), but it does vary according to the 
prevalence of the problem (17). 
The target population comprised any adult or child 
attending the practice for any reason who reported 
even having had asthma. Each receptionist used a 
standard written question to screen 100 consecutive 
patients attending the practitioner. Eligible patients 
reported asthma symptoms or treatment within the 
previous 12 months, and were asked to complete an 
asthma questionnaire, and to give an asthma question- 
naire to their doctor at the time of their consultation. 
The patient questionnaire consisted of IUAT- 
validated asthma symptom questions (15) as well as 
asthma management and morbidity questions 
derived from a recent population-based Australian 
survey (1). Questions asked about currently used 
therapy, the use of peak flow meters and asthma 
action plans, office lung function assessments, and 
recent hospital and GP attendances for asthma. 
Parents completed questionnaires on behalf of 
children aged less than 12 years. 
The study used a cross-sectional analytic design, 
with proportions presented for each category of 
asthma management of interest. Analyses were 
undertaken for those with any asthma symptom 
reported 2-3 times per week or more often over the 
previous year (the ‘frequent symptoms’ group). Man- 
agement practices and morbidity were compared 
between those with and those without frequent symp- 
toms. Differences between proportions, and their 
99% confidence intervals were reported, rather than 
95% CI, to adjust for multiple testing (18). 
Results 
Participation in the study is shown in Fig. 1. Rates 
of participation, GP form completion and asthma 
prevalence did not differ significantly among the five 
geographical areas. The 4538 screened patients rep- 
resented 94% of all patients (n=4829) who attended 
these practices during the screening periods. Of these 
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Total screened: asked if they 
had ever had 
asthma n = 4538 
I I 
Matching GP and 
patient data n = 334 
Fig. 1 Participation in the asthma survey by patients and doctors. 
4538 patients, 13.4% (95% CI 12.4 & 14.4%) reported 
that they had had asthma diagnosed by a doctor in 
the past. 
The sample of 501 patients with current asthma, 
defined as symptoms or asthma treatment (in the 
previous 12 months) was used in analysis. More 
responders were female (58”/0), with males predomi- 
nating only in the O-14 years age group. These were 
similar numbers across age groups, with 149 aged less 
than 15 years, 149 aged 1544 years, and 197 aged 
over 45 years, some of whom had a mixed pattern of 
illness, reporting both asthma and other chronic 
respiratory and cardiac diseases. 
Although by definition, all patients reported that 
they had experienced some asthma symptoms or had 
used asthma medications in the previous year, only 
76.6% had seen a doctor for their asthma. Regular 
use of inhaled &agonists was reported by two-thirds 
of patients and preventive medication reported by 
one-half of the sample. Theophylline and regular oral 
steroids were used by only a minority of patients, 
most commonly in those aged over 45 years. Self- 
reported compliance was investigated, with 64.5% 
reporting that they took all or almost all of their 
regular preventive medication as prescribed. 
Only 156% of patients regularly used a peak 
flow meter to monitor their asthma, and although 
52% had a verbal action plan, only 8.7% had a 
written one. Only one-third of patients reported 
that they usually had their lung function assessed 
when they went to their doctor, and this did not 
vary by age. 
Health care utilization in the past year was 
assessed, with 11.5% having visited a hospital emer- 
gency department (ED), 20% having an emergency 
GP visit in the previoul 12 months, and 10.9% having 
been admitted to hospital for their asthma. Emer- 
gency GP and hospital ED visits were more common 
among children. Fewer than one-half of the sample 
had ever been to a specialist physician or paediatri- 
cian for their asthma, and only 13% had been within 
the past year, more frequently among children. 
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Table I Therapy, self-management and morbidity: comparison of those with frequent asthma symptoms and those with 
infrequent asthma 
Characteristic 
Frequent Infrequent Difference in 
symptoms asthma proportions 
(n=215) (%) (n=286)(%) (+99% CI) 
Patient is current smoker* 
Asthma medication 
Use daily asthma medication 
Regular inhaled &agonist bronchodilator 
Regular preventive medication (inhaled steroids 
or cromoglycate) 
Regular theophylline use 
Regular oral steroid use 
Asthma monitoring, medical care 
Own a peak flow meter (PFM) 
Used PFM (weekly or >once/week) 
Lung function measured in doctor’s surgery 
(always/sometimes) 
Have a written asthma action plan 
Had inhaler technique checked in past 12 months 
Health care utilization and morbidity 
Any Accident and Emergency visit previous 
12 months 
Emergency GP visit in the previous 12 months 
Asthma hospital admission in the previous 12 months 
Routine GP visit for asthma in the past 3 months 
Visited a specialist for their asthma in past 
12 months 
Absence from school or work for at least 1 week in 
the past 12 months 









































*Analysis confined to adults ( t 15 years); tPcO.01. 
Of those 293 who reported that they were at work 
or school, 48% reported time off because of asthma in 
the previous year, 36% reporting l-7 days off, and 
12% reporting losing more than 7 days. In children 
aged less than 14 years, three-quarters reported some 
school absence, and over one-fifth reported more 
than a week off school. 
Table 1 shows the prevalence of asthma manage- 
ment practices in the 215 patients (43%) with more 
frequent symptoms (at least 2-3 times per week). 
Frequent symptoms were reported by 26% of those 
aged less than 14 years, 46% of those aged 15-44 
years, and 55% of those older than 45 years. One-fifth 
of adults with frequent symptoms reported that they 
smoked, which was slightly but not significantly more 
than those with less frequent symptoms. 
A greater proportion of those with frequent symp- 
toms used inhaled &agonists and regular preventive 
medication compared to those with less frequent 
symptoms. However, the rates of preventive medica- 
tion use were still low, reported by only two-thirds of 
those with frequent symptoms. Overall, peak flow 
meter ownership and having a written asthma action 
plan did not differ by symptom frequency, but office 
lung function assessment was more likely in the 
symptomatic group. 
Emergency department visits, hospital admissions, 
specialist doctor visits and GP visits in the previous 
12 months were significantly more common in those 
with frequent symptoms. Absences from school or 
work were no more likely in the more symptomatic 
group (Table 1). 
The relationship between patient- and doctor- 
reported asthma management is shown in Table 2, 
and was derived from a sub-sample of the 501 
responders. This matched group of 334 respondents 
was comprised of patients who had been to their 
GP for asthma in the previous 12 months, and for 
whom medical record information was available. 
The matched sample (n = 334) was under-represented 
in the 1544 years age group (24.8% compared to 
30.1% overall), and were more likely than the 
remaining 167 patients to report weekly wheeze 
symptoms (38.5% compared with 28.3%; P<O.Ol), 
take daily asthma medication (68.8% compared 
with 47.5%; P<O.Ol), and to have been admitted to 
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Table 2 Matched analysis (matched sample n=334) comparing patients’ report with general practitioners’ perceptions 
GP Patient Positive 
perception perception Kappa Sensitivity Specificity predictive 
Parameter (%I W) ( f 95% CI) (se) (SP) value ( + PV) 
Patient is a current smoker 
Patient using regular inhaled 
bronchodilator 
Patient using regular 
preventive therapy 
Patient using regular 
theophylline medication 
Patient using regular oral 
steroids 
Regular peak flow meter 
user 
Have written action plan 
three or more GP visits 
in past 3 months 
Admitted to hospital for 
asthma in past year 
Have seen specialist for 
asthma (in past year) 
12.0 11.6 0.75 (0640.86) 0.89 0.98 0.77 
91.0 71.2 0.48 (0.34-0.63) 0.75 0.70 0.96 
71.0 55.6 0.61 (0.524.69) 0.76 0.94 0.97 
17.4 16.1 0.71 (0.614.81) 0.74 0.95 0.77 
11.4 9.0 0.67 (0.540.81) 0.63 0.98 0.80 
35.1 14.9 0.25 (0.17-0.33) 0.34 0.93 0.41 
13.8 10.5 0.42 (0.28-0.57) 0.43 0.95 0.44 
18.8 20.5 0.40 (0.3CLO.50) 0.87 0.64 0.74 
14.1 14.1 0.7 1 (0.60-0.8 1) 0.84 0.97 0.67 
19.1 17.5 0.70 (0.560.73) 0.67 0.94 0.64 
hospital for asthma in the previous year (13.8%, 
64%; P<O.OOl). 
There was good agreement regarding smoking 
status, with little misclassification between doctors’ 
and patients’ reports (Table 2). Doctors reported 
higher rates of prescribing /&-agonist and preventive 
medication than was reported by patients. For exam- 
ple, doctors reported that 91% of patients were 
prescribed bronchodilators, when only 71% of 
patients reported using them; similarly, doctors pre- 
scribed preventive medication for 71%, but only 
556% of patients reported regular use. Misclassifica- 
tion occurred as follows: 75 of the 304 patients whom 
the doctors reported as having been prescribed 
inhaled &agonists were not actually using them 
(Se=0.75). Conversely, nine of the 30 patients whom 
the doctors thought were not using inhaled 
&agonists were actually doing so (Sp=O.70). None- 
theless, given the high rates of usage of these medi- 
cations, positive predictive values were higher than 
for the less prevalent theophylline and oral cortico- 
steroid use, although measures of agreement between 
doctor and patient were better for these latter two 
medication groups. 
Compared to GP reporting, patients underesti- 
mated their use of written action plans. Here, doctors 
identified 46 patients who had received an action 
plan, but only 20 of those patients reported that they 
had one (Se=0.43). Doctors reported that 35% of 
patients were using a peak flow meter at least weekly, 
whereas only 14.9% of patients reported doing so 
(Se=0.34). Given the low prevalence of these behav- 
iours, the positive predictive values were lower than 
for medication use. 
In addition, doctors identified 148 patient records 
with a recent FEV, or PEFR recording in the surgery 
(44%) whereas fewer patients (32%) recalled that 
their doctors ‘always/sometimes’ measured their lung 
function in the surgery; these doctor and patient 
measures were not identical so formal agreement was 
not assessed. 
Health care utilization measures showed reason- 
able agreement between doctor and patient, except 
for recent visits to the GP, whom 50 of 140 patients 
thought they had visited in the past 3 months, when 
the GP had no record of this, leading to the modest 
specificity (0.64) and kappa (0.40) values. 
Measures of agreement [kappa (K) statistics] in 
Table 2 were compared across age categories, and 
by symptom frequency. No trends were noted for 
bronchodilator or preventive medication groups, but 
agreement about theophylline use was greater in the 
frequently symptomatic group (h-=0.83) than in the 
less frequent group (~=0.44, WO.01). Similar, but 
non-significant trends were noted for agreement with 
oral corticosteroid use by symptom frequency 
(~=0.58, 0.72) and agreement increased with age 
category (~=0.37, 0.65, 0.75). Agreement between 
doctor and patient was generally higher for more 
symptomatic patients, and those aged over 45 years, 
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especially regarding reported healthy care utilization. 
This difference was significant only for ‘recent GP 
visits’ for those aged over 45 years, where ~=0.50, 
significantly higher than for younger patients (pooled 
Ic=o.30, P<O.Ol). 
Discussion 
The results of this reflect the ongoing sub-optimal 
management of asthma in relation to recommended 
population guidelines, but demonstrates the potential 
for misclassification of estimates which rely on 
patient reports. This indicates that patient-reported 
asthma management may underestimate that pro- 
vided by doctors in the population. The study com- 
prised a representative sample of patients and 
practices, and included patients with asthma present- 
ing to their practitioner for any reason, not necessar- 
ily for their asthma. Within this study, management 
and morbidity did not differ among regions, but the 
sample size was too small to examine inter- 
practitioner comparisons. Representativeness was 
also more likely as the present study estimated rates 
of diagnosed asthma and medication prescribing 
patterns similar to other Australian research (1,6). 
This study confirmed previous observations that 
asthma is a condition predominantly managed in 
primary medical care (4,6,10). However, not all of 
these asthma patients attended for regular review, 
with 25% of the whole sample having had no review 
by a doctor within the past year, and almost 40% of 
those with frequent symptoms reporting having no 
medical attendance for asthma in the previous 3 
months. 
As with other GP-based studies (13,19), patients 
reported more frequent symptoms and greater levels 
of morbidity than in population-based studies due to 
the selection effect of those studied in this setting 
(1,21). Over one-third of patients reported asthma 
symptoms at least twice per week, suggesting at least 
moderate asthma. Morbidity was considerable, with 
one-half of the patients reporting some time off work 
or school due to their asthma, and one-sixth of 
patients reporting a hospital admission or A&E visit 
in the previous 12 months. The proportion reporting 
time off work or school was not related to asthma 
severity in this study, suggesting that a range of 
factors may influence absenteeism (20). 
Studies in clinic settings have suggested that 
improving patient monitoring, and increased use of 
preventive medication may reduce the morbidity 
associated with chronic asthma (22,23). Sub-optimal 
asthma management against published recommenda- 
tions (2) was evident in that fewer than one-half of 
the patients reported using any preventive medica- 
tion, and only one-fifth owned a peak flow meter to 
assess the severity of their asthma. Patients with 
frequent symptoms are particularly at risk (2), and 
reported higher rates of medication use and morbid- 
ity. However, even within this group, one-third used 
no preventive medication, and only small propor- 
tions monitored their asthma or had written action 
plans. Further, only one-third of patients reported 
that their GP ‘always or sometimes’ measured their 
airway function in the surgery, which was a major 
recommendation of published asthma management 
guidelines (2,3). 
One-sixth of the sample were current cigarette 
smokers, a recognized precipitant of asthma episodes 
in many patients (19). Unexpectedly, self-reported 
smoking was significantly more common in the more 
frequent symptom group. This has been previously 
reported in Australian adolescents with asthma (24), 
but the cognitive antecedents of smoking in asthma 
are not understood. 
Doctors’ actual management of asthma was less 
good than an earlier self-reported survey of general 
practitioners would suggest. A national sample of 
500 GPs in 1990 reported that they used preventive 
medication in over 80% of their patients, and 79% of 
them measured airway function on ‘most or some’ 
visits by patients with asthma (25). The findings of 
the present survey suggest that doctors are doing 
better than patient surveys would suggest, but not as 
well as doctors’ own reports of their practice. 
The patients for whom matched data were avail- 
able (n = 334, with both GP and patient reports) were 
a more severe sub-sample of the 501 responders, on 
the basis of more frequent asthma symptoms, and 
more health care utilization than those 167 without 
comparable GP estimates. The matched analysis 
showed that patients’ use of medication and self- 
management practices were considerably less good 
than doctors believed them to be. The criterion or 
standard used as the GPs’ view, as they assessed 
management from reading the patient’s medical 
record. As only patients who had attended the 
practice for asthma were included, it is likely that 
this method ascertained true prescriptions and 
recommended management advice. 
The differences between patient and doctor reports 
may have occurred because doctors prescribed medi- 
cation or recommended certain practices to patients, 
but these were not remembered or adhered to (26,27). 
From an epidemiological point of view, estimates 
from patient-based surveys may underestimate the 
true prevalence of doctors’ asthma management 
practices, and paint an unnecessarily negative view of 
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the prescribing and counselling habits of doctors. 
Problems with compliance with recommended 
therapy and management advice are widely recog- 
nized (23), but their effect on patient-derived preva- 
lence estimates needs to be considered in future 
research. 
Positive predictive values were lower for the less 
prevalent practices, such as ownership of peak flow 
meters and action plans. This makes it more difficult 
for doctors to judge levels of these behaviours in their 
practice populations. 
The results from the present study of medical 
practice attenders may represent a best-case scenario 
for asthma management, compared to general popu- 
lation samples (1,28) or studies of those who obtain 
bronchodilator medication exclusively over the coun- 
ter from pharmacists (21,29). The GPs who partici- 
pated did not differ substantially from those who 
declined, but may have been more motived with 
respect to asthma care. The patients were drawn from 
geographically and socio-economically diverse prac- 
tices, but prevalence, management and morbidity did 
not differ among regions, as has been observed 
previously (1). 
Conclusions 
The present study provided data from a diverse 
group of people with moderately severe asthma. The 
observed differences between doctor and patient 
reports of management suggest that epidemiological 
studies should not rely exclusively on patient self- 
reports. In addition, patient and doctor perceptions 
differed enough to suggest that communication 
barriers may have contributed to reduced adherence 
with recommended advice. Strategies to inform GPs 
about the complexities of asthma management have 
been disseminated through the Australian National 
Asthma Campaign (25,30,31). Further education for 
GPs should emphasize the problems of patient under- 
standing and adherence to recommended advice, and 
the need for medical review and reinforcement. 
Methods of teaching patients need to be improved, 
perhaps using ancillary practice nurses or health 
educators (11). Patients need to develop greater 
responsibilities in the collaborative management of 
their asthma, and need to maintain self-management 
behaviour beyond their interval episodes of acute 
asthma. 
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